Skip to main content

Main menu

  • HOME
  • ARTICLES
    • Current Issue
    • Abstracts In Press
    • Archives
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • Other Publications
    • abfm

User menu

Search

  • Advanced search
American Board of Family Medicine
  • Other Publications
    • abfm
American Board of Family Medicine

American Board of Family Medicine

Advanced Search

  • HOME
  • ARTICLES
    • Current Issue
    • Abstracts In Press
    • Archives
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • JABFM on Bluesky
  • JABFM On Facebook
  • JABFM On Twitter
  • JABFM On YouTube
Research ArticleArticle

Pain Management by the Family Physician: The Family Practice Pain Education Project

Edward T. Bope, Alan B. Douglass, Alan Gibovsky, Tanya Jones, Laeth Nasir, Trish Palmer, Sunil Panchal, Francine Rainone, Peter Rives, Knox Todd and James D. Toombs
The Journal of the American Board of Family Practice November 2004, 17 (suppl 1) S1-S12; DOI: https://doi.org/10.3122/jabfm.17.suppl_1.S1
Edward T. Bope
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alan B. Douglass
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alan Gibovsky
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tanya Jones
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laeth Nasir
MBBS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Trish Palmer
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sunil Panchal
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francine Rainone
PhD, DO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Rives
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Knox Todd
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James D. Toombs
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    Figure 1.

    The patient as the center of care.

  • Figure 2.
    • Download figure
    • Open in new tab
    Figure 2.

    WHO analgesic ladder.

Tables

  • Figures
    • View popup
    Table 1.

    Step 1 Nonopioid Analgesics

    Drug (Brand name) Rx or OTCUsual Starting DoseMaximum Daily DoseCommentsCost/day*
        Acetaminophen (Tylenol, others) OTC650 mg q4–6 hours4000 mg1000 mg is more effective than 650 mg in some patients<$1.00
        Aspirin (various) OTC650 mg q4–6 hours4000 mgMay not be tolerated as well as some newer NSAIDs.<$1.00
        Diflunisal (Dolobid) Rx1000 mg ×1 then 500 mg q12 hours1500 mgDerived from salicylic acid. Little antipyretic activity$2.80
    Nonacetylated Salicylates
        Choline magnesium trisalicylate (Trilisate, others) Rx1500 mg ×1 then 1000 mg q12 hours3000 mgEffective anti-inflammatory drugs, but less effective analgesics than aspirin. Have minimal antiplatelet effect and do not alter bleeding time. Aspirin cross-sensitivity less likely to occur.$3.00
        Salsalate (Disalcid, others) Rx1500 mg ×1 then 1000 mg q12 hours3000 mg$2.50
    Other NSAIDs: Propionic Acid
        Fenoprofen (Nalfon, others) Rx200 mg q4–6 hours1200 mg90% eliminated by the kidney.$3.40
        Flurbiprofen (Ansaid, others) Rx50 mg q8–12 hours300 mgAt high doses, monitor closely for side effects.$1.00
        Ibuprofen (Rx: Motrin, others; OTC: Advil, Nuprin, others)400 mg q4–6 hours; OTC use: 200–400 mg q4–6 hours2400 mg; OTC 1200 mg200 mg ≈ 650 mg aspirin or APAP. 400 mg ≈ codeine/APAP$1.60
        Ketoprofen (Rx: Orudis, others; OTC: Actron, Orudis-KT)25–50 mg q6–8 hours; OTC use: 12.5–25 mg q4–6 hours300 mg; OTC 75 mg12.5 mg ≈ 200 mg ibuprofen; 50 mg superior to codeine/APAP$3.60
        Naproxen (Naprosyn, others) Rx500 mg ×1 then 500 mg q12 hours or 250 mg q6–8 hours1250 mg first day then 1000 mg250 mg ≈ 650 mg aspirin with longer duration. 95% eliminated by the kidney.<$1.00
        Naproxen sodium (Rx: Anaprox, others; OTC: Aleve, others)550 mg ×1 then 550 mg q12 hours or 275 mg q6–8 hours; OTC use: 220–440 mg ×1 then 220 mg q8–12 hours1375 mg first day then 1100 mg; OTC 660 mg275 mg ≈ 650 mg aspirin with longer duration; OTC 440 mg ≈ 400 mg ibuprofen. 95% eliminated by the kidney. Naproxen sodium may have less dyspepsia than naproxen<$1.00
        Oxaprozin (Daypro) Rx600–1200 mg qd1800 mgLong serum half-life (42–50 hours)$1.66
    Other NSAIDs: Acetic Acid
        Diclofenac potassium (Cataflam, others) Rx50 mg q8 hours or 75 mg bid150 mgMay have less dyspepsia than the sodium salt.$1.10
        Diclofenac sodium (Voltaren, others; extended-release: Voltaren XR, others) Rx50 mg q8 hours or 75 mg bid; extended-release 100 mg qd150 mg; for Voltaren XR 100 mgAlso available with misoprostol 200 μg (Arthrotec 50 mg, 75 mg) to decrease GI toxicity.$1.00
        Etodolac (Lodine, others; extended-release: Lodine XL) Rx200–400 mg q6–8 hours; Lodine XL 400 mg qd1200 mg; for Lodine XL 1000 mg200 mg ≈ 650 mg aspirin or APAP$2.70
        Indomethacin (Indocin, other; sustained release: Indocin SR, others) Rx25 mg q8–12 hours; sustained release 75 mg qd200 mg; for Indocin SR 75 mg bidHigher incidence of side effects. Also available in oral suspension.<$1.00
        Ketorolac (Toradol)10 mg q4–6 hours40 mg91% eliminated by the kidney. Use lower dose if >65 years or <50kg. Do not use >5 days$3.70
        Sulindac (Clinoril, others) Rx150–200 mg bid400 mgHave few cases reporting less drug interaction with lithium<$1.00
        Tolmetin (Tolectin, others;) Rx200–600 tid1800 mg100% eliminated by the kidney.$1.65
    Other NSAIDs: Fenamates
        Meclofenamate (various) Rx50–100 mg q4–6 hours400 mgComparable with aspirin. Commonly used for dysmenorrhea. Diarrhea is common$1.10
        Mefenamic acid (Ponstel) Rx500 mg ×1 then 250 mg q6 hours1250 mgEffective in dysmenorrhea. Do not use >1 week$5.20
    Other NSAIDs: Naphthylalkanone
        Nabumetone (Relafen) Rx1000 mg qd2000 mgCan be given either qd or bid$2.40
    Other NSAIDs: Oxicam
        Meloxicam (Mobic) Rx7.5 mg qd15 mgDose-dependent COX-2/COX-1 inhibition$2.00
        Piroxicam (Feldene, others) Rx20 mg qd20 mgLong serum half-life (50 hours). High incidence of side effects, especially in the elderly.<$1.00
    COX-2 Inhibitors
        Celecoxib (Celebrex) RxAcute pain: 400–600 mg first day, then 200 mg bid400 mgContraindicated in sulfa allergy$4.70
        Valdecoxib (Bextra) RxDysmenorrhea: 20 mg bid40 mgApproved for osteoarthritis/rheumatoid arthritis and dysmenorrhea only$5.40
    Injectable NSAIDs
        Ketorolac IV/IM (Toradol) Rx<65 years: 60 mg ×1 then 30 mg q6 hours; ≥65 years: 30 mg ×1 then 15 mg q6 hours120 mg91% eliminated by the kidney. Use lower dose if >65 or <50kg. Do not use >5 days$7.99 ea dose
    • * Cost/day = cost of usual daily dosage based on price listing at www.drugstore.com on 2003 Oct 21. Generic drugs were used whenever available.

    • qid, 4 times per day; tid, 3 times per day; bid, twice per day; qd, once per day; q, every.

    • View popup
    Table 2.

    Commonly Used Step 2 Agents

    DrugExamples of Brand NameUsual Adult Dose*Cost†
    Opioid Analgesic Combination (Controlled Drug Schedule)
        Codeine/APAP (C-III)Tylenol #2 15/300, Tylenol #3 30/300, Tylenol #4 60/300; Liquid 12/120/5 mL (c-v)60 mg q 3–4 hours or 1–2 tab q4 hours; 15 mL q 4 hours$7–14/30s$6–10/120 mL
        Codeine/aspirin (C-III)Empirin #3 30/325, Empirin #4 60/32560 mg q 3–4 hours or 1–2 tab q 4 hours$5–8/30s
        Hydrocodone/APAP (C-III)Lorcet-HD 5/500, Lorcet plus 7.5/650, Lorcet 10/650; Lortab 2.5/500, 5/500, 7.5/500; Vicodin 5/500, Vicodin ES 7.5/750, Vicodin HP 10/660; Lortab elixir 2.5/167/5 mL10 mg q 3–4 hours or 1–2 tab q 3–4 hours$14–25/30s
        Hydrocodone/ibuprofen (C-III)‡Vicoprofen 7.5/2001 tab q 4–6 hours$32.55/30s
        Oxycodone/APAP (C-II)Percocet 2.5/325, 5/325, 7.5/500, 10/650; Roxicet 5/325, 5/500; Tylox 5/50010 mg q 3–4 hours$6–24/30s
        Oxycodone/aspirin (C-II)Percodan-Demi 2.5/325, Percodan 5/32510 mg q 3–4 hours$7–17/30s
        Propoxyphene napsylate/APAP (C-IV)Darvocet-N 50 50/325, Darvocet-N 100 100/650100 mg q 4 hours$9–16/30s
        Propoxyphene/APAP (C-IV)Wygesic 65/6501 tab q 4 hours$6–9/30s
    Other Step 2 Agents
        Tramadol‡Ultram 50 mg50–100 mg q 4–6 hours$25/30s
        Tramadol/APAP‡Ultracet 37.5/3251–2 tab q 4–6 hours$25/30s
    • * The total dose of acetaminophen or aspirin should be <4 g/day.

    • † Cost based on generic pricing listed in 2001 Drug Topics Redbook.

    • ‡ Not available in generic.

    • APAP, acetaminophen; q, every.

    • View popup
    Table 3.

    Commonly Used Step 3 Opioids

    DrugDosage Form (Brand Name)Usual Adult DosageCost*
    Immediate-Release Product
        MorphineIV: 1, 2, 4, 5, 8, 10, 15, 25, 50 mg/mLIV: 2–10 mg$18–30/100s tab; $9–13/100 mL liquid; $15–30/12s supp
    Tablets: 15, 30 mg (MSIR, generic)SC/IM: 10 mg q4 hours
    Liquid: 10 mg/5 mL, 20 mg/5 mL, 20 mg/mL, 100 mg/5 mL (Roxanol, others)PO: 10–30 mg q4 hours
    Suppositories: 5, 10, 20, 30 mg (various)Rectal: 10–20 mg q4 hours
        HydromorphoneIV: 1, 2, 4, 10 mg/mL (Dilaudid, others)IV/IM/SC: 1–4 q4–6 hours$37–70/100s tab; $22/6s supp
    Tablets: 1, 2, 3, 4, 8 mg (Dilaudid, others)PO: 2–6 mg q3–4 hours
    Liquid: 5 mg/5 mL (Dilaudid, others)Rectal: 3 mg q6–8 hours
    Suppositories: 3 mg (Dilaudid, others)
        OxycodoneTablets: 5 mg (Percolone, Roxicodone)PO: 10–30 mg q 4 hours$30–36/100s tab
    Capsules: 5 mg (OxyIR)
    Liquid: 5 mg/5 mL (Roxicodone), 20 mg/mL (Roxicodone Intensol, OxyFAST)
        Meperidine†IV: 10, 25, 50, 75, 100 mg/mL (various)IV/IM/SC: 50–100 mg q3–4 hours$68/100s tab
    Tablets: 50, 100 mg (Demerol, various)PO: 50–100 mg q3–4 hours
    Liquid: 50 mg/5 mL (Demerol, various)
    Sustained-Release Products‡
        Morphine Sustained-Release§SR Tablets: 15, 30, 60, 100, 200 mg (MS Contin, Oramorph SR)Not recommended for initial therapy$90, $171, $334, $511/100s tabs
        Oxycodone Controlled-Release§CR Tablets: 10, 20, 40, 80 mgOpioid-naive patients: 10 mg q 12 hours, and titrate$124, $238, $422, $793/100s
        Fentanyl Transdermal PatchTransdermal Patch: 25, 50, 75, 100 μg/hr (Duragesic)Opioid-naïve patients: 25 μg/hr every 3 days$62, $102, $163, $203/5s
    Opioids with Long Duration of Action‡
        LevorphanolTablets: 2 mg (Levo-Dromoran)PO: 2–4 mg q 6–8 hours$87/100s
        MethadoneTablets: 5, 10, 40 mg (Dolophine, others, generic)PO: 5–20 mg Q 6–8 hours$9, $15, $37/100s
    • * Cost based on generic pricing listed in 2001 Drug Topics Redbook.

    • † Not recommended for cancer pain.

    • ‡ Not recommended for initial therapy.

    • § Tablets are not to be chewed or crushed.

    • View popup
    Table 4.

    Opioid Equianalgesic Dosing Chart

    Drug (Common Trade Name)Dose (mg) Equianalgesic to 10 mg SC/IV MorphineSC/IV:PO ratioDuration of Action (Hours)
    SC/IVPO/PR
    Morphine (MSIR, Roxanol)1030*3:13–4
    Codeine (with aspirin or APAP)130180–2001.5: 13–4
    Hydrocodone (in Lortab, Vicodin, others)NA30NA3–4
    Hydromorphone (Dilaudid)1.57.55:13–4
    Levorphanol (Levo-Dromoran)242:16–8
    Meperidine (Demerol)1003003:13
    Methadone (Dolophine, others)10 for acute 2–4 for chronic20 for acute 2–4 for chronic2:1†6–8‡
    Oxycodone (Roxicodone, also in Percocet, Percodan, others)NA30NA3–4
    • * IV/PO ratio (1:3) is based on chronic dosing. IM/PO ratio of 1:6 for single dose or intermittent dosing.

    • † Oral administration results in delayed onset and lower peak.

    • ‡ Duration and half-life increase with chronic dosing.

    • APAP, acetaminophen; IM, intramuscular; PO, by mouth; SC, subcutaneous; IV, intravenous.

    • View popup
    Table 5.

    Initial Duragesic Dose Based on Daily Oral Morphine Dose

    Oral 24-hr Morphine (mg/day)Duragesic Dose (μg/hr)
    45–13425
    135–22450
    225–31475
    315–404100
    405–494125
    495–584150
    585–674175
    675–764200
    765–854225
    855–944250
    945–1034275
    1035–1124300
    • Source: Duragesic package insert.

    • View popup
    Table 6.

    Agents to Relieve Constipation

    ClassDrug and DosageEstimated Cost/Dose*
    Stimulant LaxativesBisacodyl (Dulcolax, Correctol, others): 5–10 mg orally$0.30–0.60
    Senna (Senokot, others): 17.2 mg at bedtime$0.15–0.30
    Osmotic LaxativesLactulose (Cephulac, others): 15–30 mL bid (may be administered orally or rectally)$0.62–1.25
    Polyethylene glycol (MiraLax): 17 g/day in 8 oz of water$1.30
    Sorbitol 70% solution: 15–30 mL bid (may be administered orally or rectally)$0.25–0.50
    Emollient LaxativesDocusate (Colace, others): 200–800 mg/day in 2 divided doses$0.05–0.20
    Combination AgentsDocusate (50 mg) plus senna (8.6 mg) tablets (Senokot–S, others): 2–4 tablets once or twice daily$0.30–0.60
    • * Cost is estimated using prices listed at www.drugstore.com (2004 Mar). Generic drugs were used whenever available.

    • bid, twice daily.

PreviousNext
Back to top

In this issue

The Journal of the American Board of Family Practice: 17 (suppl 1)
The Journal of the American Board of Family Practice
Vol. 17, Issue suppl 1
1 Nov 2004
  • Table of Contents
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Board of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Pain Management by the Family Physician: The Family Practice Pain Education Project
(Your Name) has sent you a message from American Board of Family Medicine
(Your Name) thought you would like to see the American Board of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
10 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Pain Management by the Family Physician: The Family Practice Pain Education Project
Edward T. Bope, Alan B. Douglass, Alan Gibovsky, Tanya Jones, Laeth Nasir, Trish Palmer, Sunil Panchal, Francine Rainone, Peter Rives, Knox Todd, James D. Toombs
The Journal of the American Board of Family Practice Nov 2004, 17 (suppl 1) S1-S12; DOI: 10.3122/jabfm.17.suppl_1.S1

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Pain Management by the Family Physician: The Family Practice Pain Education Project
Edward T. Bope, Alan B. Douglass, Alan Gibovsky, Tanya Jones, Laeth Nasir, Trish Palmer, Sunil Panchal, Francine Rainone, Peter Rives, Knox Todd, James D. Toombs
The Journal of the American Board of Family Practice Nov 2004, 17 (suppl 1) S1-S12; DOI: 10.3122/jabfm.17.suppl_1.S1
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Definitions
    • The Prevalence of Pain
    • Fundamental Principles of Pain Management
    • Conclusion
    • Notes
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Diversity in Family Medicine Research
  • Answering the “100 Most Important Family Medicine Research Questions” from the 1985 Hames Consortium
  • Mentoring for the Diverse Range of Family Physicians’ Engagement in Research
Show more Articles

Similar Articles

Navigate

  • Home
  • Current Issue
  • Past Issues

Authors & Reviewers

  • Info For Authors
  • Info For Reviewers
  • Submit A Manuscript/Review

Other Services

  • Get Email Alerts
  • Classifieds
  • Reprints and Permissions

Other Resources

  • Forms
  • Contact Us
  • ABFM News

© 2025 American Board of Family Medicine

Powered by HighWire